Watch the video HERE! Linda Hodgkins, MS, OTR/L, CLT-LANA delivered the Keynote Presentation for Klose Conference 2019. Linda believes going back to the basics of Complete Decongestive Therapy (CDT) will dramatically improve patient outcomes and facilitate program growth.
Read more →The Obesity and Obesity-Related Lymphedema & Lipedema online course created and presented by Tobias Bertsch, MD, delves into the misconceptions related to obesity and offers evidence-based information that counters the myths. The course is subdivided in four “Acts.”
Read more →Watch the livestream HERE! As a follow-up to the well-received livestream for LE&RN on May 15th, Klose Training is pleased to make the following resources available for educational purposes and reference…
Read more →Watch Video HERE! Guenter Klose responds to a recent article addressing the appropriate dosing of Complete Decongestive Therapy (CDT) for lymphedema patients and shares his own personal experiences on the topic.
Read more →Watch Video HERE! During the Klose Lymphedema Conference in Denver, Colorado in May, 2017, Saskia R. J. Thiadens, RN, was honored for her tireless advocacy on behalf of individuals living with lymphedema and other lymphatic disorders.
Read more →Developer Jan Weiss has worked diligently to establish what change in a patient’s LLIS scores is actually statistically significant. The psychometrics are as follows: MCID (minimal clinically important difference) is 7.31 and MDC95 (minimal detectable change) is 11.53. This means that if your patient scores more than 7 points better from their pre- to post-treatment LLIS scores, there has been clinically-significant improvement.
Read more →The conversion from ICD-9 to ICD-10 coding is likely to cause confusion for all health care professionals involved in lymphedema care. In this link, ICD-10-CM Expansions of Lymphedema Diagnostic Codes, you’ll find a helpful conversion list that was compiled by LymphActivist Robert Weiss, M.S.
Read more →In 2013, the Centers for Medicare and Medicaid (CSM) mandated the use of functional limitation reporting for documentation as a means to base treatment, set goals, and substantiate third-party payment. The selection of appropriate “G” code for patients being treated for lymphedema can be difficult, especially when the individual’s functional level is normal or high. Assistance with documentation can be found using a reference, the International Classification of Functioning, Disability and Health (ICF)1, originating from a document developed by the World Health Organization (WHO) in 1980.
Read more →In this instructional video, Vicki Ralph, MPPA, OTR/L, CLT-LANA, demonstrates Self-MLD techniques while providing clear verbal instruction. Vicki has been involved for nearly a decade in educating patients with lymphedema on ways to self-manage the swelling related to their condition. Self-MLD can help decrease pain and improve their range of motion, mobility, and activities of daily living.
Read more →The incidence of obesity has been on a stunning and rapid rise in the United States, as well as globally, for the last thirty to forty years. The public health impact is significant. Links between obesity and many indicators of poor health, most notably cardiovascular disease, Type 2 diabetes, and some types of cancer, are well established. Because of the unique interrelationship between the lymphatic system and adipose tissue, the implications for individuals with, or at risk for, lymphedema are profound.
Read more →
